SOME RESULTS OF STUDY USAGE OF MAIN DRUGS IN THE TREATMENT FOR PEPTIC ULCE
- VernacularTitle: ХОДООД , ДЭЭД ГЭДЭСНИЙ ШАРХЛАА ӨВЧНИЙ ҮЕД ХЭРЭГЛ ЭГДДЭГ ЭМИЙН
- Author:
Л.Уламбаяр
1
;
Á.Áàÿðöýöýã1
;
Л.Хүрэлбаатар2
;
С.Мөнхбат3
;
Р.Цэрэнлхагва4
;
Х.Оюунцэцэг5
Author Information
1. 2Монос Дээд Сургууль
- Publication Type:Journal Article
- Keywords:
: peptic ulcer;
disease;
helicobacter pylori;
main drug;
drug use
- From:
Mongolian Pharmacy and Pharmacology
2012;1(1):27-33
- CountryMongolia
- Language:Mongolian
-
Abstract:
Introduction:The main purpose of health organizations, hospitals and pharmaceutical assistant service organizations are supplying active, efficient and high quality estimation for a treatment, reasonable priced, safe and guaranteed drugs to the people and the health organizations constantly. Digestive system especially peptic ulcer which is one of the disease and its occurrence is high in the population and might be increased further . The reason of death caused by peptic ulcer which takes fourth place in the five prior reason of death . Statistics of digestive organ system’s hospitalized disease is 92363 including 3218 peptic ulcer disease in Mongolia and its 1533 incidence was registered in Ulaanbaatar by 2010. Goal of study: The aim of the study was to determine items and real usage of drugs which are used in the stationary treatment of patients who are suffering from peptic ulcerin the II,III hierarchy hospitals of Ulaanbaatar and within the propose of determining demands and real usage of main drugs for treatment of peptic ulcer especially and sickness rate of digestive system and its occurrence is high in the population of Mongolia. Objectives of the study:Identify disease prognosis and disease genetic from the health statistic report of digestive organ system disease which is most common in population particularly peptic ulcer. Identify the concrete list of drugs which is used for peptic ulcer patients who is having stationary hospital treatment in the II,III hierarchy hospitals in Ulaanbaatar, Mongolia. Conclusion: The major causes of peptic ulcer are stomach acid increasing and contagion. Infection with a type of bacteria called Helicobacter pylori. Purpose of the research work is reveal the drug consuming of treatment eradication Helicobacter pylori, determine up and down trend of the peptic ulcer and suggest the proper usage of drug. Additive or synergistic effects in eradication of H.pylori have been produced by combining two antibiotics with either bismuth ranitidine citrate or proton pump inhibitors.European consensus is that although many options are available, the emerging treatment of choice is seven-day proton-pump-based triple therapy with either omeprazole or Lansoprazole plus two antibiotics (any two of clarithromycin, metronidazole and or amoxicillin). From the survey III hierarchy hospitals didn’t use latest antibiotic clarithromycin and proton pump inhibitor , bismuth, gastroprotecting and treatments pantoprazole, famotidine, quamatel, venter, denol, sucralfate, zantac and zapazid. The II,III hierarchy hospitals used the above mentioned drugs in short terms by few amounts. The cause of not using expensive potent pharmakinetic drugs not often is hospital budget limit and not registered Mongolian drug registrations and not penetrated market. 28 types of main drug were used in the treatment of patients who were suffered from peptic ulcer and treated in the hospital. So 78448.00 thousand tugrik will be spent in the treatment of peptic ulcer. Key word: peptic ulcer,disease, helicobacter pylori, main drug, drug use
